Research & Literature

Assessment of the Non-Cystic Fibrosis Bronchiectasis Severity: The FACED Score vs the Bronchiectasis Severity Index.

Minov J, Karadzinska-Bislimovska J, Vasilevska K, et al.

The open respiratory medicine journal 2015; (9()):46-51 doi:10.2174/1874306401509010046.

Factors Associated With Quality of Life in Subjects With Stable COPD.

Ekici A, Bulcun E, Karakoc T, et al.

Respiratory care 2015; (60(11)):1585-91 doi:10.4187/respcare.03904.

Eradication Therapy against Pseudomonas aeruginosa in Non-Cystic Fibrosis Bronchiectasis.

Orriols R, Hernando R, Ferrer A, et al.

Respiration; international review of thoracic diseases 2015; (90(4)):299-305 doi:10.1159/000438490.

A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis.

Finch S, McDonnell MJ, Abo-Leyah H, et al.

Annals of the American Thoracic Society 2015; (12(11)):1602-11 doi:10.1513/AnnalsATS.201506-333OC.

Acidic pH increases airway surface liquid viscosity in cystic fibrosis.

Tang XX, Ostedgaard LS, Hoegger MJ, et al.

The Journal of clinical investigation 2016; (126(3)):879-91.

Mucus Hyperconcentration as a Unifying Aspect of the Chronic Bronchitic Phenotype.

Button B, Anderson WH, Boucher RC

Annals of the American Thoracic Society 2016; (13 Suppl 2()):S156-62 doi:10.1513/AnnalsATS.201507-455KV.

Asthma and risk of bronchiectasis exacerbation: we still need more evidence.

Gao YH, Guan WJ, Chen RC, Zhang GJ

The European respiratory journal 2016; (48(4)):1246-1247 doi:10.1183/13993003.00780-2016.

Factors related to depression and anxiety in adults with bronchiectasis.

Özgün Niksarlioglu EY, Özkan G, Günlüoğlu G, et al.

Neuropsychiatric disease and treatment 2016; (12()):3005-3010 doi:10.2147/NDT.S121147.

Short-Term Effect of Autogenic Drainage on Ventilation Inhomogeneity in Adult Subjects With Stable Non-Cystic Fibrosis Bronchiectasis.

Poncin W, Reychler G, Leeuwerck N, et al.

Respiratory care 2017; (62(5)):524-531 doi:10.4187/respcare.05194.

The development and validation of the Bronchiectasis Health Questionnaire.

Spinou A, Siegert RJ, Guan WJ, et al.

The European respiratory journal 2017; (49(5)) doi:10.1183/13993003.01532-2016.

Gel-forming mucins form distinct morphologic structures in airways.

Ostedgaard LS, Moninger TO, McMenimen JD, et al.

Proceedings of the National Academy of Sciences of the United States of America 2017; (114(26)):6842-6847 doi:10.1073/pnas.1703228114.

Association between environmental factors and hospitalisations for bronchiectasis in Badalona, Barcelona, Spain (2007-2015).

Garcia-Olivé I, Radua J, Sánchez-Berenguer D, et al.

Medicina clinica 2018; (150(7)):257-261 doi:10.1016/j.medcli.2017.06.022.

The therapeutic potential of CFTR modulators for COPD and other airway diseases.

Solomon GM, Fu L, Rowe SM, Collawn JF

Current opinion in pharmacology 2017; (34()):132-139 doi:10.1016/j.coph.2017.09.013.

The Bronchiectasis Severity Index and FACED score for assessment of the severity of bronchiectasis.

Costa JC, Machado JN, Ferreira C, et al.

Pulmonology 2018; (24(3)):149-154 doi:10.1016/j.rppnen.2017.08.009.

Computed tomography in adult patients with primary ciliary dyskinesia: Typical imaging findings.

Dettmer S, Ringshausen F, Vogel-Claussen J, et al.

PloS one 2018; (13(2)):e0191457 doi:10.1371/journal.pone.0191457.

Bronchiectasis in severe asthma: Clinical features and outcomes.

Coman I, Pola-Bibián B, Barranco P, et al.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2018; (120(4)):409-413 doi:10.1016/j.anai.2018.02.016.

The annual prognostic ability of FACED and E-FACED scores to predict mortality in patients with bronchiectasis.

de la Rosa Carrillo D, Athanazio R, Girón Moreno RM, et al.

ERJ open research 2018; (4(1)) doi:10.1183/23120541.00139-2017.

A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: A tertiary care experience.

Satırer O, Mete Yesil A, Emiralioglu N, et al.

Respiratory medicine 2018; (137()):35-39 doi:10.1016/j.rmed.2018.02.013.

Prevention of exacerbations in patients with stable non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis of pharmacological and non-pharmacological therapies.

Abu Dabrh AM, Hill AT, Dobler CC, et al.

BMJ evidence-based medicine 2018; (23(3)):96-103 doi:10.1136/bmjebm-2018-110893.

The Role of the Immune Response in the Pathogenesis of Bronchiectasis.

King PT

BioMed research international 2018; (2018()):6802637 doi:10.1155/2018/6802637.

Inhaled corticosteroids for bronchiectasis.

Kapur N, Petsky HL, Bell S, et al.

The Cochrane database of systematic reviews 2018; (5()):CD000996 doi:10.1002/14651858.CD000996.pub3.

Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis.

Schäfer J, Griese M, Chandrasekaran R, et al.

BMC pulmonary medicine 2018; (18(1)):79 doi:10.1186/s12890-018-0630-8.

Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study.

Mac Aogáin M, Chandrasekaran R, Lim AYH, et al.

The European respiratory journal 2018; (52(1)) doi:10.1183/13993003.00766-2018.

Dual antibiotics for bronchiectasis.

Felix LM, Grundy S, Milan SJ, et al.

The Cochrane database of systematic reviews 2018; (6()):CD012514 doi:10.1002/14651858.CD012514.pub2.

Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.

Li W, Qin Z, Gao J, et al.

Chronic respiratory disease 2019; (16()):1479972318790269 doi:10.1177/1479972318790269.

Management of bronchiectasis in adults.

Visser SK, Bye P, Morgan L

The Medical journal of Australia 2018; (209(4)):177-183 doi:10.5694/mja17.01195.

Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis.

Hsieh MH, Lin CY, Wang CY, et al.

Infection and drug resistance 2018; (11()):1137-1143 doi:10.2147/IDR.S169789.

Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis.

Contarini M, Shoemark A, Rademacher J, et al.

Multidisciplinary respiratory medicine 2018; (13(Suppl 1)):26 doi:10.1186/s40248-018-0143-6.

Bronchiectasis.

McShane PJ, Tino G

Chest 2019; (155(4)):825-833 doi:10.1016/j.chest.2018.10.027.

Medical management of bronchiectasis.

O'Donnell AE

Journal of thoracic disease 2018; (10(Suppl 28)):S3428-S3435 doi:10.21037/jtd.2018.09.39.

British Thoracic Society Guideline for bronchiectasis in adults.

Hill AT, Sullivan AL, Chalmers JD, et al.

Thorax 2019; (74(Suppl 1)):1-69 doi:10.1136/thoraxjnl-2018-212463.

Airway clearance, mucoactive therapies and pulmonary rehabilitation in bronchiectasis.

O'Neill K, O'Donnell AE, Bradley JM

Respirology (Carlton, Vic.) 2019; (24(3)):227-237 doi:10.1111/resp.13459.

British Thoracic Society guideline for bronchiectasis in adults.

Hill AT, Sullivan AL, Chalmers JD, et al.

BMJ open respiratory research 2018; (5(1)):e000348 doi:10.1136/bmjresp-2018-000348.

Effect of airway clearance techniques in patients experiencing an acute exacerbation of bronchiectasis: a systematic review.

Phillips J, Lee A, Pope R, Hing W

Physiotherapy theory and practice 2020; (36(12)):1300-1315 doi:10.1080/09593985.2019.1579286.

Is there a place for dornase alfa therapy in lung transplantation?

Harlander M, Vos R, Kneževič I

Transplant international : official journal of the European Society for Organ Transplantation 2019; (32(6)):598-599 doi:10.1111/tri.13414.

Pharmacotherapeutic strategies for treating bronchiectasis in pediatric patients.

Lee E, Hong SJ

Expert opinion on pharmacotherapy 2019; (20(8)):1025-1036 doi:10.1080/14656566.2019.1589453.

Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis.

Wang D, Fu W, Dai J

Medicine 2019; (98(17)):e15285 doi:10.1097/MD.0000000000015285.

Pregnancy Zone Protein Is Associated with Airway Infection, Neutrophil Extracellular Trap Formation, and Disease Severity in Bronchiectasis.

Finch S, Shoemark A, Dicker AJ, et al.

American journal of respiratory and critical care medicine 2019; (200(8)):992-1001 doi:10.1164/rccm.201812-2351OC.

The microbiome in bronchiectasis.

Richardson H, Dicker AJ, Barclay H, Chalmers JD

European respiratory review : an official journal of the European Respiratory Society 2019; (28(153)) doi:10.1183/16000617.0048-2019.

Bronchoscopic instillation of DNase to manage refractory lobar atelectasis in a lung cancer patient.

Assallum H, Song TY, DeLorenzo L, Harris K

Annals of translational medicine 2019; (7(15)):363 doi:10.21037/atm.2019.05.15.

Non-antimicrobial airway management of non-cystic fibrosis bronchiectasis.

Egan AM, Clain JM, Escalante P

Journal of clinical tuberculosis and other mycobacterial diseases 2018; (10()):24-28 doi:10.1016/j.jctube.2017.12.003.

Etiology and characteristics of patients with bronchiectasis in Taiwan: a cohort study from 2002 to 2016.

Huang HY, Chung FT, Lo CY, et al.

BMC pulmonary medicine 2020; (20(1)):45 doi:10.1186/s12890-020-1080-7.

Noncystic Fibrosis Bronchiectasis: Evaluation of an Extensive Diagnostic Protocol in Determining Pediatric Lung Disease Etiology.

Beckeringh NI, Rutjes NW, van Schuppen J, Kuijpers TW

Pediatric allergy, immunology, and pulmonology 2019; (32(4)):155-162 doi:10.1089/ped.2019.1030.

Non-CF bronchiectasis: Orphan disease no longer.

Imam JS, Duarte AG

Respiratory medicine 2020; (166()):105940 doi:10.1016/j.rmed.2020.105940.

[Bronchiectasis - a review].

Gudmundsson G, Juliusson G

Laeknabladid 2020; (106(7)):352-361 doi:10.17992/lbl.2020.0708.592.

Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis.

Xu MJ, Dai B

Therapeutic advances in respiratory disease 2020; (14()):1753466620936866 doi:10.1177/1753466620936866.

Prognostic performance of the FACED score and bronchiectasis severity index in bronchiectasis: a systematic review and meta-analysis.

He M, Zhu M, Wang C, et al.

Bioscience reports 2020; (40(10)) doi:10.1042/BSR20194514.

New-onset nontuberculous mycobacterial pulmonary disease in bronchiectasis: tracking the clinical and radiographic changes.

Kwak N, Lee JH, Kim HJ, et al.

BMC pulmonary medicine 2020; (20(1)):293 doi:10.1186/s12890-020-01331-3.

A study of the psychometric properties of the Brazilian...Portuguese version of Bronchiectasis Health Questionnaire.

Luppo A, de Camargo CO, Birring SS, et al.

Pulmonology 2023; (29(1)):42-49 doi:10.1016/j.pulmoe.2020.10.012.

Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications.

Kwok WC, Ho JCM, Tam TCC, et al.

Respiratory research 2021; (22(1)):132 doi:10.1186/s12931-021-01729-5.

Association Between Non-Cystic Fibrosis Bronchiectasis and Quality of Life: A Single-Center Cross-Sectional Study.

Chaurasia S, Haran A, Reddy A, Chawla P

Cureus 2021; (13(3)):e14231 doi:10.7759/cureus.14231.

Refining diagnostic criteria for paediatric bronchiectasis using low-dose CT scan.

Wu J, Bracken J, Lam A, et al.

Respiratory medicine 2021; (187()):106547 doi:10.1016/j.rmed.2021.106547.

Re: Effectiveness of hypertonic saline nebulization in airway clearance in children with noncystic fibrosis bronchiectasis: A randomized control trial.

Valji R, Mehta R, Hicks A

Pediatric pulmonology 2021; (56(12)):4051-4052 doi:10.1002/ppul.25656.

Impact of bronchial wall thickness on airflow obstruction in bronchiectasis.

Yamamoto Y, Kuge T, Miki K, et al.

Respiratory physiology & neurobiology 2022; (295()):103788 doi:10.1016/j.resp.2021.103788.

Cystic Fibrosis Transmembrane Conductance Regulator: Roles in Chronic Obstructive Pulmonary Disease.

Dransfield M, Rowe S, Vogelmeier CF, et al.

American journal of respiratory and critical care medicine 2022; (205(6)):631-640 doi:10.1164/rccm.202109-2064TR.

The Predictive Role of Psychological Status and Disease Severity Indexes on Quality of Life Among Patients with Non-CF Bronchiectasis.

Ceyhan B, Bekir M, Kocakaya D, et al.

Turkish thoracic journal 2022; (23(1)):17-24 doi:10.5152/TurkThoracJ.2021.21142.

Effect of exercise-based pulmonary rehabilitation in patients with bronchiectasis: A meta-analysis.

Yang F, Gao L, Wang Q, et al.

Respiratory medicine and research 2022; (81()):100910 doi:10.1016/j.resmer.2022.100910.

Impacts of Nontuberculous Mycobacteria Isolates in Non-cystic Fibrosis Bronchiectasis: A 16-Year Cohort Study in Taiwan.

Lin CY, Huang HY, Hsieh MH, et al.

Frontiers in microbiology 2022; (13()):868435 doi:10.3389/fmicb.2022.868435.

Genome sequencing reveals underdiagnosis of primary ciliary dyskinesia in bronchiectasis.

Shoemark A, Griffin H, Wheway G, et al.

The European respiratory journal 2022; (60(5)) doi:10.1183/13993003.00176-2022.

Correlation among clinical, functional and morphological indexes of the respiratory system in non-cystic fibrosis bronchiectasis patients.

Perossi J, Koenigkam-Santos M, Perossi L, et al.

PloS one 2022; (17(7)):e0269897 doi:10.1371/journal.pone.0269897.

The efficacy of azithromycin to prevent exacerbation of non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled studies.

Li K, Liu L, Ou Y

Journal of cardiothoracic surgery 2022; (17(1)):266 doi:10.1186/s13019-022-01882-y.

Ancillary treatment of patients with lung disease due to non-tuberculous mycobacteria: a narrative review.

Youssefnia A, Pierre A, Hoder JM, et al.

Journal of thoracic disease 2022; (14(9)):3575-3597 doi:10.21037/jtd-22-410.

Antibody deficiencies with normal IgG in adults with Non-cystic fibrosis bronchiectasis or recurrent pneumonia: Cross-sectional study.

Zea-Vera AF, Chacón MA, Parra B

Colombia medica (Cali, Colombia) 2022; (53(2)):e2014832 doi:10.25100/cm.v53i2.4832.

Sputum pathogen spectrum and clinical outcomes of upper respiratory tract infection in bronchiectasis exacerbation: a prospective cohort study.

Huang Y, Chen CL, Cen LJ, et al.

Emerging microbes & infections 2023; (12(1)):2202277 doi:10.1080/22221751.2023.2202277.

Basic, translational and clinical aspects of bronchiectasis in adults.

Chalmers JD, Elborn S, Greene CM

European respiratory review : an official journal of the European Respiratory Society 2023; (32(168)) doi:10.1183/16000617.0015-2023.

The prevalence of anxiety and depression in bronchiectasis patients and their association with disease severity: a cross-sectional study.

Al Oweidat K, Marie D, Toubasi AA, et al.

Scientific reports 2023; (13(1)):20886 doi:10.1038/s41598-023-48276-1.

Prescribing preferences and availability of nebulisers and inhalers for inhaled medications in bronchiectasis: results of a specialist survey.

Shteinberg M, Spinou A, Goeminne P, et al.

ERJ open research 2024; (10(1)) doi:10.1183/23120541.00724-2023.

Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis.

Conceição M, Shteinberg M, Goeminne P, et al.

European respiratory review : an official journal of the European Respiratory Society 2024; (33(171)) doi:10.1183/16000617.0178-2023.

Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC).

Polverino E, Dimakou K, Traversi L, et al.

The Journal of allergy and clinical immunology 2024; (153(6)):1553-1562 doi:10.1016/j.jaci.2024.01.027.

[Bronchiectasis not due to cystic fibrosis].

Girón R, Golpe R, Martínez-García MÁ

Medicina clinica 2024; (163(2)):81-90 doi:10.1016/j.medcli.2024.01.023.

Bronchiectasis management in adults: state of the art and future directions.

Choi H, McShane PJ, Aliberti S, Chalmers JD

The European respiratory journal 2024; (63(6)) doi:10.1183/13993003.00518-2024.

Inhaled Medications for Maintenance Therapy in Pediatric Noncystic Fibrosis Bronchiectasis.

Harvath Gray EM, Pettit RS, Engdahl S

The Annals of pharmacotherapy 2025; (59(5)):446-462 doi:10.1177/10600280241279602.

Efficacy and safety of long-term macrolide therapy for non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.

Nakagawa N, Ito M, Asakura T, et al.

Respiratory investigation 2024; (62(6)):1079-1087 doi:10.1016/j.resinv.2024.09.004.

[Management of adult bronchiectasis - Consensus-based Guidelines for the German Respiratory Society (DGP) e. V. (AWMF registration number 020-030)].

Ringshausen FC, Baumann I, de Roux A, et al.

Pneumologie (Stuttgart, Germany) 2024; (78(11)):833-899 doi:10.1055/a-2311-9450.

The prevalence and implications of depression and anxiety in patients with bronchiectasis: a systematic review and meta-analysis.

Chang MS, Kim HJ, Lee JH

ERJ open research 2024; (10(6)) doi:10.1183/23120541.00248-2024.

Non-Cystic Fibrosis Bronchiectasis in Adults: A Review.

Barker AF, Karamooz E

JAMA 2025; (334(3)):253-264 doi:10.1001/jama.2025.2680.

Bronchiectasis evaluation 2025: pediatric and adult perspectives.

Tolle J, O'Connor M

Current opinion in pulmonary medicine 2025; (31(6)):622-627 doi:10.1097/MCP.0000000000001217.

The impact of dornase alfa on imaging features of bronchiectasis.

Mingora CM, Mollica F, Caudri D, et al.

Research square 2025; doi:10.21203/rs.3.rs-6991583/v1.

Non-cystic fibrosis bronchiectasis in Taiwan.

Chang CL, Sheu CC, Wang PH, et al.

BMJ open respiratory research 2025; (12(1)) doi:10.1136/bmjresp-2024-003100.

Prospective Study of <italic>Aspergillus</italic> IgG and Clinical Outcomes in Patients with Bronchiectasis.

Yang J, Zhang K, Lu S, et al.

Respiration; international review of thoracic diseases 2026; (105(3)):360-369 doi:10.1159/000548741.

Bronchiectasis Treatment Goals, Unmet Needs, and Emerging Therapies: A Podcast.

Flume PA, Maselli DJ

Pulmonary therapy 2026; (12(1)):1-12 doi:10.1007/s41030-025-00330-1.

Association between gastroesophageal reflux disease and incident bronchiectasis: a nationwide representative population-based study in Korea.

Yoon J, Yoon JH, Lee H, et al.

BMC pulmonary medicine 2025; (26(1)):7 doi:10.1186/s12890-025-04011-2.